Program
Break
Ceremony/Networking
Debate Session
Free Communications
Poster Viewing
Scientific Session
Sponsored Sessions
Break
Ceremony/Networking
Debate Session
Free Communications
Poster Viewing
Scientific Session
Sponsored Sessions
| Time | Ballroom CDE | Ballroom AB | Exhibition |
|---|---|---|---|
| 12:55-13:00 |
Brief Welcome
|
||
| 13:00-14:00 |
Debate 01: What Should We Use As the First-Line Treatment for RA?
|
Debate 02: Are the New Classification Criteria a Step Forward in the Management of Antiphospholipid Syndrome?
|
|
| 14:10-15:10 |
Debate 03: LN Treatment: Early Combination vs. Standard Treatment
|
Debate 04: The Use of Medical Cannabis in Rheumatic Pain Management: Valid Option or Unproven Treatment?
|
|
| 15:10-15:40 |
Coffee Break, Exhibition and E-Poster Discussions
|
||
| 15:40-16:40 |
Sponsored Session
|
||
| 16:50-17:50 |
Scientific Session 01: Rheumatoid Arthritis and Pain
|
Free Communications 01
|
Poster Viewing Walks
|
| 18:00-19:00 |
Opening Ceremony
|
||
| 19:00-20:00 |
Welcome Reception
|
| Time | Ballroom CDE | Ballroom AB | Exhibition | Offsite |
|---|---|---|---|---|
| 08:30-09:00 |
Sponsored Session
|
Sponsored Session
|
||
| 09:05-10:05 |
Debate 05: Beyond Physical Examination – How to Approach to RA Management: Joint Ultrasound or Synovial Biopsy?
|
Debate 06: Mepolizumab in EGPA: Does One Size Fit All?
|
||
| 10:05-10:45 |
Coffee Break and Exhibition
|
|||
| 10:10-10:40 |
Sponsored Session
|
|||
| 10:45-11:45 |
Debate 07: TNFi or IL17i for the Slowing the Radiographic Progression in Spondyloarthritis?
|
Debate 08: Gut Microbiome in Rheumatic Diseases: Revolutionary or Fake News?
|
||
| 11:50-12:50 |
Debate 09: CAR-T Cells in Rheumatic Diseases: Game-Changer or Just a Buzz?
|
Debate 10: Is Seronegative Sjogren Syndrome a Distinct Clinical Entity? & Should Hydroxychloroquine Be Used in Patients With Sjogren Syndrome?
|
||
| 12:50-13:50 |
Lunch Break, Exhibition and E-Poster Discussions
|
|||
| 13:00-14:00 |
Sponsored Session
|
|||
| 14:05-15:05 |
Free Communications 02
|
Free Communications 03
|
Poster Viewing Walks
|
|
| 15:10-16:10 |
Debate 11: Early Biologic Treatment in Systemic Lupus: Necessary or Overemphasized?
|
Debate 12: Is Hematopoietic Stem Cell Transplantation (Really) a Valid Option for Patients With Systemic Sclerosis?
|
||
| 16:10-16:50 |
Coffee Break and Exhibition
|
|||
| 16:15-16:45 |
Sponsored Session
|
Sponsored Session
|
||
| 16:50-17:50 |
Debate 13: Can We Give Targeted Therapies in Patients With Cancer?
|
Debate 14: Are IPAF and UCTD Two Clinical Variants of the Same Systemic Autoimmune Disorder?
|
||
| 17:55-18:55 |
Debate 15: Do JAK Inhibitors Aggravate Comorbidities Such As Cardiovascular Disease and Cancer?
|
Free Communications 04
|
||
| 19:30-22:00 |
Networking Event
|
| Time | Ballroom CDE | Ballroom AB | Exhibition |
|---|---|---|---|
| 09:00-10:00 |
Debate 16: Should We Treat preRA/at Risk RA Individuals or Not?
|
Debate 17: Is It Common To Achieve the T2T Goals in SLE Patients?
|
|
| 10:00-10:30 |
Coffee Break and Exhibition
|
||
| 10:30-11:30 |
Scientific Session 02: Prevention in Autoimmunity
|
Free Communications 05
|
|
| 11:35-12:35 |
Debate 18: Axial Psoriatic Arthritis and axSpA: To Lump or to Split
|
Debate 19: Should Immunosuppressive Drugs Be Used in All Patients With the Limited Cutaneous Form of SSc?
|
|
| 12:35-13:35 |
Lunch Break, Exhibition and E-Poster Discussions
|
||
| 12:45-13:45 |
Sponsored Session
|
||
| 13:50-14:50 |
Scientific Session 03: Chat GPT vs. Hippocrates in Autoimmunity
|
Free Communications 06
|
|
| 14:55-15:55 |
Debate 20: Is It Safe to Use Low-Dose Glucocorticoids in GCA?
|
Debate 21: Transition From Psoriasis to Psoriatic Arthritis: Are We Getting Closer?
|
|
| 15:55-16:30 |
Award Ceremony
|